J. Navenot

发表

Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists.

P. Atadja, K. Bhalla, N. Fujii, 2010, Blood.

Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy.

Kedar S Vaidya, J. Kappes, M. Accavitti-Loper, 2007, Journal of the National Cancer Institute.

Association of Nucleophosmin Negatively Regulates CXCR4-Mediated G Protein Activation and Chemotaxis

N. Fujii, S. Peiper, J. Navenot, 2007, Molecular Pharmacology.

Constitutive Activation of CCR5 and CCR2 Induced by Conformational Changes in the Conserved TXP Motif in Transmembrane Helix 2*

J. Broach, S. Peiper, J. Navenot, 2003, Journal of Biological Chemistry.

Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.

A. Rapoport, R. Amado, L. Melchiori, 2019, Blood advances.

KiSS1 Metastasis Suppressor Gene Product Induces Suppression of Tyrosine Kinase Receptor Signaling to Akt, Tumor Necrosis Factor Family Ligand Expression, and Apoptosis

N. Fujii, S. Peiper, J. Navenot, 2009, Molecular Pharmacology.

CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.

Oana A. Tomescu, M. Ratajczak, F. Barr, 2002, Blood.

Pilot study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII+ glioblastoma.

K. Mansfield, Sumei Wang, S. Brem, 2016 .

Production of a New Murine Monoclonal Antibody with Fy6 Specificity and Characterization of the Immunopurified N‐Glycosylated Duffy‐Active Molecule

M. Benbunan, J. Muller, D. Blanchard, 1994, Vox sanguinis.

Physical association of GPR54 C-terminal with protein phosphatase 2A.

N. Fujii, S. Peiper, J. Navenot, 2008, Biochemical and biophysical research communications.

Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.

G. Tsujimoto, N. Fujii, H. Ohno, 2012, Bioconjugate chemistry.

S‐protein is expressed in necrotic fibers in Duchenne muscular dystrophy and polymyositis

J. Louboutin, D. Blanchard, J. Navenot, 2003, Muscle & nerve.

Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers

A. Malandrini, M. Villanova, J. Louboutin, 1997, Muscle & nerve.

Structure-activity relationship study on small peptidic GPR54 agonists.

N. Fujii, H. Ohno, S. Oishi, 2006, Bioorganic & medicinal chemistry.

Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity.

J. Broach, A. Otaka, H. Tamamura, 2006, Bioorganic & medicinal chemistry letters.

The metastasis suppressor KISS1 lacks antimetastatic activity in the C8161.9 xenograft model of melanoma

N. Fujii, S. Oishi, S. Peiper, 2012, Melanoma research.

X‐linked vacuolated myopathy: Membrane attack complex deposition on the surface membrane of injured muscle fibers is not accompanied by S‐protein

M. Villanova, M. Fardeau, L. Merlini, 1998, Muscle & nerve.

Collagen matrix: an attractive alternative to agar and methylcellulose for the culture of hematopoietic progenitors in autologous transplantation products.

I. Dobo, V. Praloran, J. Navenot, 1995, Journal of hematotherapy.

Cytolytic effect of human anti‐Gal IgM and complement on porcine endothelial cells: A kinetic analysis

J. Soulillou, L. Borche, D. Blanchard, 1994 .

Role of CD4 hinge region in GP120 utilization by immunoglobulin domain 1.

J. Murray, S. Peiper, J. Navenot, 2002, Biochemical and biophysical research communications.

Characterization of constitutively active mutants of G protein-coupled receptors.

Zi-Xuan Wang, S. Peiper, J. Navenot, 2006, Methods in molecular biology.

A Point Mutation That Confers Constitutive Activity to CXCR4 Reveals That T140 Is an Inverse Agonist and That AMD3100 and ALX40-4C Are Weak Partial Agonists*

J. Broach, B. Haribabu, H. Tamamura, 2002, The Journal of Biological Chemistry.

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.

Daniel K. Wells, S. Grupp, W. Tap, 2018, Cancer discovery.

Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

G. Demetri, S. Grupp, B. V. Van Tine, 2019, Journal of Immunotherapy for Cancer.

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

K. Mansfield, S. Brem, D. O’Rourke, 2017, Science Translational Medicine.

Expression of blood group i antigen and fetal hemoglobin in paroxysmal nocturnal hemoglobinuria

D. Blanchard, J. Navenot, Jordon Mullet, 1997, Transfusion.

New method for quantitative determination of fetal hemoglobin-containing red blood cells by flow cytometry: application to sickle-cell disease.

T. Merghoub, R. Ducrocq, R. Krishnamoorthy, 1998, Cytometry.

Characterization of the receptor binding residues of kisspeptins by positional scanning using peptide photoaffinity probes.

N. Fujii, H. Ohno, T. Noguchi, 2013, Bioorganic & medicinal chemistry letters.

MicroRNA Profiling in Lung Cancer Reveals New Molecular Markers for Diagnosis

R. Vadigepalli, Zi-Xuan Wang, C. Solomides, 2012, Acta Cytologica.

Heat Shock Response in CHO Mammalian Cells Is Controlled by a Nonlinear Stochastic Process

Lei Huang, Zixuan Wang, Ovidiu Lipan, 2007, PLoS Comput. Biol..

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

Matthew J. Frigault, R. Sullivan, D. Hong, 2022, Frontiers in Oncology.

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

Matthew J. Frigault, R. Govindan, Melissa L. Johnson, 2022, Journal for ImmunoTherapy of Cancer.

Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.

D. Bernard, J. Harousseau, J. Muller, 1996, Leukemia & lymphoma.

379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor

D. Hong, P. Fracasso, S. Saibil, 2020 .

Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With the Development of Necrotizing Acute Pancreatitis

A. Gulbinas, G. Barauskas, Zi-Xuan Wang, 2014, Pancreas.

Flow cytometry and immunoblotting analysis of monoclonal antibodies directed to complement regulatory proteins.

D. Blanchard, J. Navenot, M. Loirat, 1997, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors.

Melissa L. Johnson, D. Hong, P. Fracasso, 2020 .

Activation of Rho and Rho-Associated Kinase by GPR54 and KiSS1 Metastasis Suppressor Gene Product Induces Changes of Cell Morphology and Contributes to Apoptosis

N. Fujii, S. Peiper, J. Navenot, 2009, Molecular Pharmacology.

Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes

J. Muller, D. Blanchard, J. Navenot, 1998, Transfusion.

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

F. Bushman, Melissa L. Johnson, B. V. Van Tine, 2023, Nature Medicine.

IMCT-15PILOT STUDY OF T CELLS REDIRECTED TO EGFRvIII WITH A CHIMERIC ANTIGEN RECEPTOR IN PATIENTS WITH EGFRvIII+ GLIOBLASTOMA

Donald M. O'Rourke, Suyash Mohan, Eileen Maloney, 2015 .

Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.

J. Murray, J. Trent, P. Moore, 2001, Journal of molecular biology.

278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer

Matthew J. Frigault, R. Govindan, Melissa L. Johnson, 2020 .

Activation of Rho and ROCK by GPR54 and KiSS1 Metastasis Suppressor Gene Product Induces Changes of Cell Morphology and Contributes to Apoptosis

N. Fujii, S. Peiper, J. Navenot, 2009 .

Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins.

N. Fujii, S. Peiper, J. Navenot, 2005, Cancer research.

Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.

J. Murray, J. Trent, G. Tomaras, 2000, Journal of molecular biology.

KiSS1 Metastasis Suppressor Gene Product Induces Suppression of Tyrosine Kinase Receptor Signaling to Akt, Tumor Necrosis Factor Family Ligand Expression, and Apoptosis

N. Fujii, S. Peiper, J. Navenot, 2009, Molecular Pharmacology.

Abstract LB-083: Phase I study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII+ glioblastoma

K. Mansfield, Sumei Wang, S. Brem, 2016 .

Activation of Rho and Rho-Associated Kinase by GPR54 and KiSS1 Metastasis Suppressor Gene Product Induces Changes of Cell Morphology and Contributes to Apoptosis

N. Fujii, S. Peiper, J. Navenot, 2009, Molecular Pharmacology.

Contents Vol. 56,2012

Jesse S. Voss, M. Bibbo, G. Giaccone, 2012, Acta Cytologica.